APAC Automated Breast Ultrasound Systems Market to hit $742mn by 2024

 Request a sample

According to the Graphical Research new growth forecast report titled “Asia Pacific Automated Breast Ultrasound Systems Market analysis based on Product, End-Use, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 - 2024”, estimated to exceed USD 742 million by 2024.

Rising awareness coupled with initiatives for breast cancer will significantly impact Asia Pacific automated breast ultrasound systems market growth in upcoming period. Countries across Asia Pacific observe October month as National Breast Cancer Awareness Month. The Pink Initiative, India works to spread awareness, support women affected by breast cancer through online forums and educate women about the disease. Such efforts and initiatives will accelerate ABUS screening adoption rate and stimulate market growth.

Increasing number of national programs for breast cancer screening will augment Asia Pacific ABUS industry growth. National breast screening programs aims at early detection of breast cancer that significantly cuts treatment costs. For instance, BreastScreen Australia program launched by the Australian government offers free breast screening test for women between 50 years and 74 years age. Such programs will provide attractive market growth opportunities during the forthcoming years.

Dearth of skilled professionals across the region coupled with high investment in ABUS devices and lack of proper reimbursement policies can impede ABUS business growth in Asia Pacific during the recent years.

Automated Breast Volume Scanner (ABVS) segment will show growth at rapid pace at 18.0% CAGR over the projected timeframe. Generation of 3D images that assists detection of breast cancer in asymptomatic women as well as overcomes the limitations of handheld ultrasound systems. ABVS is also used in combination with mammography systems for better diagnosis of the disease. Such benefits will contribute to high segmental growth in forthcoming years.

Diagnostic imaging centers segment will grow at remarkable rate of 18.0% CAGR over the forecast period. Growing healthcare infrastructure will positively impact segmental share across Asia Pacific. Numerous diagnostic centers across Asia Pacific are equipped with ABUS or ABVS systems for early detection of breast cancer. For instance, GE Invenia automated breast ultrasound (ABUS) is exclusively available in Benson Radiology in Australia. Growing demand for enhanced screening of breast cancer will spur segmental growth.

 

Japan automated breast ultrasound systems market will foresee fast growth at 18.3% CAGR over the forecast period. Increasing incidence of breast cancer and installation of novel technology products for breast screening will play a major role in stimulating industrial growth in the nation. The Japanese government has introduced Japan Strategic Anti-Cancer Randomized Trial (J-START), a study to compare combined screening of mammography and ABUS to improve accuracy of cancer screening. Such efforts will highly impact JAPAN ABUS market growth.

Prominent industry players involved in Asia Pacific automated breast ultrasound systems market are GE Healthcare, Hitachi Ltd., Koninklijke Philips N.V., Siemens AG, and SonoCine Inc. Companies are focusing on novel product launch and partnerships to establish strong foothold in the market.

Segments we cover:

Asia Pacific Automated Breast Ultrasound Systems Market, By Product

  • Automated Breast Ultrasound System
  • Automated Breast Volume Scanner
  • Others

Asia Pacific Automated Breast Ultrasound Systems Market, By End-Use

  • Hospitals
  • Diagnostic Imaging Centers

The above information is provided for the following countries:

  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Malaysia
  • Indonesia
  • Thailand
  • Singapore
  • Taiwan
  • Philippines
  • Vietnam